# NeuroBell

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurobell

- Industry: Medical Devices & Equipment
- Headquarters: Cork, Ireland
- Website: www.neurobell.com
- Total disclosed funding: $1.7M
- Latest round: Seed (Oct 25, 2025)
- Investors on record: 4

## About

Founded in 2015 and based in Cork, Ireland, NeuroBell Ltd. operates as a medical equipment company that offers neonatal EEG monitoring solutions. The company is a spin-out of University College Cork and the Irish Centre for Maternal and Child Health Research (Infant). The firm was founded by its CEO, Mark O’Sullivan, CSO, Alison O’Shea, and CTO, Colm Murphy. In June 2026, NeuroBell Ltd. raised USD 5.5 million in venture funding led by Elkstone Ventures, with participation from Parkview Health System, Furthr VC, Atlantic Bridge, MedTech Syndicate, and Enterprise Ireland.

NeuroBell provides and develops a novel medical device that detects seizures in newborns. The company’s product line includes a pocket-sized and wireless EEG (electroencephalography) monitor, which is a medical device that leverages machine learning to detect and monitor neonatal seizures in newborns.

The company will use the June 2026 funding to launch Luna in the US and Europe and support FDA approval efforts in the US.

## Funding rounds

- Seed, Oct 25, 2025, $1.7M — Atlantic Bridge, Furthr VC, Enterprise Ireland, HBAN Angel Network

## Investors

- Atlantic Bridge (https://capitalatlas.ai/funds/atlantic-bridge) — Seed
- Furthr VC (https://capitalatlas.ai/funds/furthr-vc) — Seed
- Enterprise Ireland (https://capitalatlas.ai/funds/enterprise-ireland) — Seed
- HBAN Angel Network — Seed